This one day symposium focused on an issue of great importance to an aging society – the development of novel therapies for cognitive decline across the lifespan of humans. This meeting convened prominent basic and clinical scientists who study the cognitive and neurobiological aspects of aging and its consequences for cognition. Speakers covered three main areas: the definition of cognitive aging, the underlying neurobiology of cognitive aging, and issues in the development of potential new therapies for cognitive aging including the use of biomarkers, drug therapy and a discussion of related regulatory issues.

For more information, please visit the New York Academy of Sciences website.